<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210412050942N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-05-01</date_registration>
      <primary_sponsor>Integrated Laboratory and Research Center, University of Indonesia.</primary_sponsor>
      <public_title>Efficacy of Lotion Containing Black Rice Bran (Oryza sativa L. indica) Extract as Skin Brightening Agent, a Clinical</public_title>
      <acronym>BRBCT</acronym>
      <scientific_title>Comparison of the Efficacy of Lotion Containing Black Rice Bran (Oryza sativa L. indica) Extract with Placebo  as Skin Brightening Agent with in Healthy Asian Women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-01-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55577</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: Participants will be given 2 types of lotions to use on right and left elbows, which are applied evenly until they are absorbed. The lotions given have been coded, namely code A-right and code-B-left. This study lasted for 2 weeks (14 days). Every day, participants have to use the lotion for 14 days, twice a day in the morning and evening, each of approximately 1 gram by first washing participants' hands which will be smeared with the lotion and wiped dry. Participants are also asked to rub code A lotion on the back of participants' right hand using the finger of participants' left hand, and apply code B lotion to the back of participants' left hand using the finger of participants' right hand. This is done to prevent lotion A and lotion from mixing. Apply using participants' fingers until all of the lotion is evenly spread and absorbed well. Participants' are prohibited from washing hands at least 1 hour after using the product. Day 14, the use of the lotion is stopped and the researchers will re-check some parameters of
participants' skin's brightness level with a Mexameter tool.</study_design>
      <phase>1</phase>
      <hc_freetext>Healthy skin condition.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: one lotion containing black rice bran extract 10% is applied in one side of volunteer's volar. each application of lotion is 0,5 gram, applied in diameter 5 centimeters. Lotion is applied twice a day (every morning and evening after shower) for 14 days. the excipients of lotions are demineralized aqua, olive oil, vaseline album, dimethicone. Cetyl alcohol, isopropyl myristate, span 80, propylparaben, BHT, tween 80, methylparaben, and glycerin. They are manufactured by Brataco (Indonesia). Intervention 2: Control group: one placebo lotion were applied in the other side of volunteer's volar. each application of lotion is 0,5 gram, applied in diameter 5 centimeters. Lotion is applied twice a day (every morning and evening after shower) for 14 days. the excipients of lotions are demineralized aqua, olive oil, vaseline album, dimethicone. Cetyl alcohol, isopropyl myristate, span 80, propylparaben, BHT, tween 80, methylparaben, glycerin and colorant. They are manufactured by Brataco (Indonesia).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Afifah Kusuma Vardhani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semanggi Hill B5 Jl. Zakaria</address>
        <city>Depok</city>
        <country1>Indonesia</country1>
        <zip>16426</zip>
        <telephone>+62 622 74372722</telephone>
        <email>afifah.felani@gmail.com</email>
        <affiliation>University of Indonesia</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Afifah Kusuma Vardhani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semanggi Hill B5 Jl. Zakaria</address>
        <city>Depok</city>
        <country1>Indonesia</country1>
        <zip>16426</zip>
        <telephone>+62 622 74372722</telephone>
        <email>afifah.felani@gmail.com</email>
        <affiliation>University of Indonesia</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Indonesia</country2>
    </countries>
    <criteria>
      <inclusion_criteria>healthy skin condition;
Asian race</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>25 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>history of allergies;
pregnant or breastfeeding;
chronic medical history,
have tattoos, scars or burns;
currently using therapies such as anti-inflammatory, corticosteroids, hormonal contraceptives, or lasers;
smoke, drink alcohol and use drugs,
orally consume the test substance (black rice bran extract),
apply and consume skin brightening agent topically or orally</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: one lotion containing black rice bran extract 10% is applied in one side of volunteer's volar. each application of lotion is 0,5 gram, applied in diameter 5 centimeters. Lotion is applied twice a day (every morning and evening after shower) for 14 days. the excipients of lotions are demineralized aqua, olive oil, vaseline album, dimethicone. Cetyl alcohol, isopropyl myristate, span 80, propylparaben, BHT, tween 80, methylparaben, and glycerin. They are manufactured by Brataco (Indonesia)</i_keyword>
      <i_keyword>Control group: one placebo lotion were applied in the other side of volunteer's volar. each application of lotion is 0,5 gram, applied in diameter 5 centimeters. Lotion is applied twice a day (every morning and evening after shower) for 14 days. the excipients of lotions are demineralized aqua, olive oil, vaseline album, dimethicone. Cetyl alcohol, isopropyl myristate, span 80, propylparaben, BHT, tween 80, methylparaben, glycerin and colorant. They are manufactured by Brataco (Indonesia)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Melanin index. Timepoint: 2 weeks after intervention. Method of measurement: Measure skin melanin index with mexameter.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Integrated Laboratory and Research Center, University of Indonesia.</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-09</approval_date>
        <contact_name>The Ethics Committee, Faculty of Medicine, University of Indonesia</contact_name>
        <contact_address>Salemba Raya No 6 Jakarta Jakarta Indonesia</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
